Summary of project PR002306

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR002306. The data can be accessed directly via it's Project DOI: 10.21228/M8JR73 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

Project ID: PR002306
Project DOI:doi: 10.21228/M8JR73
Project Title:Photoaffinity ligand of Cystic Fibrosis corrector VX-445 identifies SCCPDH as an off-target
Project Type:Untargeted Metabolomics analysis
Project Summary:Cystic fibrosis (CF) pharmacological correctors such as VX-445 are used in combinations as highly effective modulator therapy (HEMT) at CF clinics due to their efficacy in improving Cystic Fibrosis transmembrane conductance regulator (CFTR) protein trafficking and function. We utilized LC-MS/MS to identify crosslinked proteins in CF bronchial epithelial cells expressing F508del CFTR, identifying SCCPDH, an uncharacterized putative oxidoreductase, as a VX-445 specific off-target. We then characterized changes in the metabolomic profiles of cells overexpressing SCCPDH to decipher its role and implications of VX-445 binding to SCCPDH-dependent metabolic changes. We found dysregulation of amino acid metabolism and a potential inhibitory activity of VX-445 on SCCPDH. The identified off-target may explain exacerbation of psychological symptoms observed in patients on HEMT, thus emphasizing the need for further optimization of corrector combinations.
Institute:Vanderbilt University
Department:Chemistry
Laboratory:Center for Innovative Technology
Last Name:CODREANU
First Name:GABRIELA SIMONA
Address:1234 STEVENSON CENTER LANE
Email:SIMONA.CODREANU@VANDERBILT.EDU
Phone:6158758422

Summary of all studies in project PR002306

Study IDStudy TitleSpeciesInstituteAnalysis
(* : Contains Untargted data)
Release
Date
VersionSamplesDownload
(* : Contains raw data)
ST003713 Photoaffinity ligand of Cystic Fibrosis corrector VX-445 identifies SCCPDH as an off-target Homo sapiens Vanderbilt University MS* 2025-08-07 1 15 Uploaded data (17.1G)*
  logo